» Articles » PMID: 3312635

Characterization of Herpesvirus Sylvilagus Glycoproteins Released into the Culture Medium of Infected Cells: Antisera to Gp13 and Gp32 Neutralize Viral Infectivity in Vitro and Identify Antigens on Plasma Membranes of Infected Cells

Overview
Journal J Virol
Date 1987 Nov 1
PMID 3312635
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Polypeptides released into the culture medium of herpesvirus sylvilagus-infected cells were identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of extracellular fluid from [35S]methionine- and [3H]glucosamine-labeled cell cultures. Virus-induced glycoproteins 31, 32, and 33 (molecular weights of 62,000, 59,000, and 54,000, respectively) were the most abundant species and appeared predominantly in the culture medium. This observation, together with the known cell-associated nature of herpesvirus sylvilagus, suggested that virus-induced glycoproteins 31, 32, and 33 were specifically released. Immunization of rabbits with virus-induced glycoproteins 13 (molecular weight of 130,000) and 32 resulted in the production of antibodies that neutralized viral infectivity in vitro. Both antiserum to gp13 and antiserum to gp32 immunoprecipitated gp13, gp26, gp33a, gp45, and virus-induced polypeptide 39 (molecular weights of 130,000, 77,000, 49,000, 27,000, and 36,000, respectively) from [35S]methionine-labeled cell extracts as well as virus-induced glycoproteins 31, 32, and 33 from the culture medium. In addition, membrane immunofluorescence assays indicate that an antigen(s) reactive with anti-gp13/32 serum was located on the plasma membrane of infected cells.

Citing Articles

Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.

Niikura M, Matsuura Y, Endoh D, Onuma M, Mikami T J Virol. 1992; 66(5):2631-8.

PMID: 1313890 PMC: 241016. DOI: 10.1128/JVI.66.5.2631-2638.1992.

References
1.
Stinski M, Mocarski E, Thomsen D, Urbanowski M . Membrane glycoproteins and antigens induced by human cytomegalovirus. J Gen Virol. 1979; 43(1):119-29. DOI: 10.1099/0022-1317-43-1-119. View

2.
Edson C, Thorley-Lawson D . Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus. J Virol. 1983; 46(2):547-56. PMC: 255157. DOI: 10.1128/JVI.46.2.547-556.1983. View

3.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

4.
Beisel C, Tanner J, Matsuo T, Kezdy F, Kieff E . Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene. J Virol. 1985; 54(3):665-74. PMC: 254850. DOI: 10.1128/JVI.54.3.665-674.1985. View

5.
Thorley-Lawson D, Geilinger K . Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity. Proc Natl Acad Sci U S A. 1980; 77(9):5307-11. PMC: 350047. DOI: 10.1073/pnas.77.9.5307. View